Tracing Multilingual Knowledge Acquisition Dynamics in Domain Adaptation: A Case Study of English-Japanese Biomedical Adaptation
By: Xin Zhao , Naoki Yoshinaga , Yuma Tsuta and more
Potential Business Impact:
Helps computers learn facts in new languages.
Multilingual domain adaptation (ML-DA) is widely used to learn new domain knowledge across languages into large language models (LLMs). Although many methods have been proposed to improve domain adaptation, the mechanisms of multilingual knowledge acquisition, how domain knowledge is learned within a language and transferred across languages, remain underexplored. This gap leads to suboptimal performance, particularly in low-resource settings. This work examines the learning dynamics of LLMs during ML-DA. Because prior ML-DA studies often train and evaluate on datasets with mismatched knowledge coverage, we propose AdaXEval, an adaptive evaluation method that builds multiple-choice QA datasets from the same bilingual domain corpus used for training, thereby directly studying multilingual knowledge acquisition. Through continual training of LLMs with diverse data recipes, we track how LLMs acquire domain facts and pinpoint the mechanism behind the transformation process from domain training data to knowledge. Our experiments on a 13B English-Japanese bilingual LLM reveal that cross-lingual transfer remains challenging despite a high-quality bilingual corpus. The code has been released.
Similar Papers
Multilingual BERT language model for medical tasks: Evaluation on domain-specific adaptation and cross-linguality
Computation and Language
Helps doctors understand patient notes in any language.
Active Domain Knowledge Acquisition with \$100 Budget: Enhancing LLMs via Cost-Efficient, Expert-Involved Interaction in Sensitive Domains
Computation and Language
Helps AI learn about medicine with expert help.
Active Domain Knowledge Acquisition with 100-Dollar Budget: Enhancing LLMs via Cost-Efficient, Expert-Involved Interaction in Sensitive Domains
Computation and Language
Helps AI learn from experts for drug discovery.